Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
Public ClinicalTrials.gov record NCT04800237. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of VQW-765 in Patients With Performance Anxiety
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in male and female participants with performance anxiety.
Study identification
- NCT ID
- NCT04800237
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 230 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 23, 2021 (Actual)
- Primary completion
- Aug 2, 2022 (Actual)
- Completion
- Aug 2, 2022 (Actual)
- Last update posted
- Mar 20, 2024
2021 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Tempe | Arizona | 85281 | — |
| Vanda Investigational Site | Beverly Hills | California | 90212 | — |
| Vanda Investigational Site | Garden Grove | California | 92845 | — |
| Vanda Investigational Site | San Jose | California | 95124 | — |
| Vanda Investigational Site | Torrance | California | 90502 | — |
| Vanda Investigational Site | Orlando | Florida | 32816 | — |
| Vanda Investigational Site | Boston | Massachusetts | 02114 | — |
| Vanda Investigational Site | North Dartmouth | Massachusetts | 02747 | — |
| Vanda Investigational Site | Las Vegas | Nevada | 89119 | — |
| Vanda Investigational Site | Berlin | New Jersey | 08009 | — |
| Vanda Investigational Site | New York | New York | 10016 | — |
| Vanda Investigational Site | Staten Island | New York | 10312 | — |
| Vanda Investigational Site | Raleigh | North Carolina | 27612 | — |
| Vanda Investigational Site | Cincinnati | Ohio | 45212 | — |
| Vanda Investigational Site | Houston | Texas | 77074 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04800237, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04800237 live on ClinicalTrials.gov.